Joycelyn Jie Xin Lee

PI3K/Akt/mTOR inhibitors in breast cancer.

Joycelyn Jie Xin Lee, Kiley Wei-Jen Loh, Yoon Sim Yap · PubMed · 2015 · 146 citations · Full text

Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial

David Tai, Kelvin Siu Hoong Loke, Apoorva Gogna et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 117 citations

Hepatology, Hepatocellular Carcinoma, Single Arm +10

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study

Changhoon Yoo, Jwa Hoon Kim, Min‐Hee Ryu et al. · Liver Cancer · 2021 · 113 citations · Full text

Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma

Samuel Chuah, Joycelyn Jie Xin Lee, Yuan Song et al. · Journal of Hepatology · 2022 · 113 citations · Full text

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma

Harry Ho Man Ng, Ren Yuan Lee, Siting Goh et al. · Journal for ImmunoTherapy of Cancer · 2020 · 112 citations · Full text